While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...
BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...
A team of scientists from the Institute of Bio- and Geosciences–Biotechnology at Forschungszentrum Jülich worked together ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...
The official made the remarks on Tuesday, addressing the 4th International Conference and Exhibition on Iranian Medical Biotech Products and Related Industries (Iran Bio) being held from February 4 to ...
1d
Zacks Investment Research on MSNShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange ...
The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support companies — ...
Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...
With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...
The Commission has introduced a new Biotech and Biomanufacturing Hub to support companies, especially start-ups and SMEs, in ...
banking on improved demand for its products and services used in developing therapies. However, some life sciences firms such as Danaher have indicated smaller biotech clients are still cautious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results